Related Experiment Video

Updated: Aug 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Optimal goals for statin use in patients with coronary artery disease

Kausik K Ray1, Christopher P Cannon

  • 1Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA. kkray@partners.org

Current Opinion in Cardiology
|October 20, 2005
PubMed

Insights

Statin therapy has transformed coronary artery disease management. This review highlights recent advancements and expert opinions on therapeutic goals for statin treatment, focusing on lipid-lowering and emerging markers like C-reactive protein.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Coronary artery disease (CAD) remains a leading cause of premature mortality globally.
  • Lipid-lowering therapies, particularly statins, have significantly improved CAD management over the last decade.
  • Recent clinical trials have expanded indications for statin therapy in CAD patients.

Purpose of the Study:

  • To review significant contributions to the literature on statin therapy in the past year.
  • To provide an expert opinion on current and future therapeutic goals for statin treatment in CAD.
  • To discuss the evolving role of traditional lipid markers and emerging targets like C-reactive protein.

Main Methods:

  • Literature review of studies published within the last year concerning statin therapy for coronary artery disease.
  • Analysis of clinical trial data and expert consensus reports.
  • Synthesis of evidence regarding efficacy of statins based on low-density lipoprotein cholesterol and C-reactive protein levels.

Main Results:

  • Statin therapy has demonstrated substantial benefits in reducing cardiovascular events.
  • Therapeutic targets for statin therapy are evolving, incorporating markers beyond LDL cholesterol.
  • Emerging targets, such as C-reactive protein, are gaining recognition for guiding treatment intensity.

Conclusions:

  • Statin therapy is a cornerstone in the management of coronary artery disease.
  • Future therapeutic strategies will likely involve personalized approaches based on a broader range of biomarkers.
  • Optimizing statin therapy requires continuous evaluation of emerging evidence and expert clinical judgment.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...